Start a live chat
1-800-870-4800
NMN and NAD+ —
the cellular relationship
that aging researchers find
most significant.
NMN is studied not for what it is, but for what it becomes. Its significance in longevity research is entirely a function of its relationship to NAD+ — one of the most consequential molecules in human biology, and one whose behavior across a lifetime has become a central organizing question for the science of aging.
I
A precursor and its destination —
understanding what the relationship means.
To understand why NMN has attracted decades of sustained attention from some of the most serious researchers in aging science, it is necessary to understand NAD+ first — what it does, why it matters, and why its behavior across the human lifespan has made it one of the defining subjects of contemporary longevity biology.
NAD+, nicotinamide adenine dinucleotide, is not a single-function molecule. It is a universal cofactor — present in every cell of the body, required by hundreds of enzymatic reactions, and central to processes ranging from the basic chemistry of cellular energy production to the sophisticated maintenance systems that cells use to repair damage, regulate gene expression, and respond to biological stress. A cell without adequate NAD+ is a cell whose most fundamental operations are compromised. And one of the most consistent findings in aging biology is that the body's ability to maintain adequate NAD+ levels erodes, systematically, as it grows older.
NMN — nicotinamide mononucleotide — sits one enzymatic step upstream of NAD+ in the Salvage Pathway, the biochemical recycling system that the body uses as its primary route for NAD+ production in adult tissue. When NMN enters a cell, the enzyme NMNAT converts it to NAD+ in a single step. No intermediate. No multi-stage conversion. The directness of this relationship — one precursor, one enzyme, one product — is a significant part of why NMN occupies the position it does in the research on NAD+ biology and aging.
What follows is an examination of that relationship in detail: what NAD+ actually does inside cells, which biological processes depend on it, how the body produces and maintains it, and what the decline of NAD+ with age means for the cellular systems that longevity science has studied most intensively.
NAD+ is not one thing.
It is the currency that dozens
of critical cellular processes
spend to function at all.
What NAD+ Does
The three major cellular roles
that make NAD+ irreplaceable.
NAD+ functions in two distinct chemical forms — as NAD+ (oxidized) and NADH (reduced) — cycling between them as it shuttles electrons through the energy metabolism pathways. Beyond energy metabolism, it serves as a substrate for three classes of enzymes whose functions are central to how cells maintain themselves across time.
Role 01
Energy metabolism substrate
In its redox role, NAD+ accepts electrons from the breakdown of glucose, fatty acids, and amino acids in glycolysis and the citric acid cycle, becoming NADH. NADH then donates those electrons to the mitochondrial electron transport chain, driving the ATP synthesis that powers every energy-dependent process in the cell. The NAD+/NADH ratio is a direct readout of the cell's metabolic state — and its dysregulation in aging tissue is associated with the mitochondrial dysfunction that longevity researchers identify as one of the primary hallmarks of cellular aging.
Role 02
Sirtuin activation substrate
Sirtuins — the seven-member family of NAD+-dependent deacylase enzymes — consume NAD+ as they regulate gene expression, coordinate DNA repair, govern mitochondrial biogenesis, and maintain the cellular stress response. Their activity is directly proportional to NAD+ availability: as NAD+ declines with age, sirtuin function is constrained. Research from multiple laboratories has established that restoring NAD+ levels in aged tissue restores sirtuin activity — and that the downstream effects of that restoration span multiple organ systems.
Role 03
DNA repair and stress response
PARP enzymes — poly(ADP-ribose) polymerases — consume NAD+ when they detect and repair DNA strand breaks. CD38, an enzyme whose expression rises with age and inflammation, degrades NAD+ as part of immune and calcium signaling. In young tissue, these demands are balanced by robust NAD+ production. In aging tissue, where DNA damage accumulates and CD38 expression increases, the same demands draw on a pool whose production has already declined — a compounding dynamic that is one of the central mechanisms behind age-related NAD+ insufficiency.
II
How the body makes NAD+ —
and why the Salvage Pathway is where NMN matters most.
The body produces NAD+ through three distinct biosynthetic routes. Understanding which routes dominate in adult human tissue — and why — is essential to understanding NMN's specific significance in the research.
The de novo pathway synthesizes NAD+ from tryptophan, an amino acid, through a multi-step enzymatic process. It is the original biosynthetic route, capable of producing NAD+ from scratch, but it is metabolically expensive and relatively slow — and its contribution to maintaining NAD+ levels in adult tissue is limited compared to the recycling pathways.
The Preiss-Handler pathway converts nicotinic acid (a form of vitamin B3) to NAD+ through three enzymatic steps. It is an efficient route but dependent on dietary nicotinic acid availability and subject to the flux limitations of its three-step conversion process.
The Salvage Pathway is the dominant NAD+ production route in most adult mammalian tissues — and it is the pathway that NMN research is fundamentally about. The Salvage Pathway recycles nicotinamide, a byproduct released every time NAD+ is consumed by sirtuins, PARPs, or CD38, back into new NAD+ molecules. The rate-limiting step in this recycling process is the conversion of nicotinamide to NMN by NAMPT — nicotinamide phosphoribosyltransferase. NAMPT activity therefore governs the pace of NAD+ replenishment in adult tissue. And NAMPT activity, research has documented, declines with age. NMN supplementation can be understood as supplying the Salvage Pathway at the step immediately downstream of its rate-limiting bottleneck — bypassing the NAMPT constraint and delivering the precursor the pathway needs to complete its final conversion to NAD+.
Understanding the Distinction
NMN and NAD+ are not the same thing —
and the distinction matters.
The molecule that travels to cells and becomes NAD+.
A nucleotide — smaller molecular weight than NAD+ itself
Orally bioavailable — absorbed and transported to tissues via the bloodstream
Converted to NAD+ inside cells by the enzyme NMNAT
Bypasses NAMPT — the rate-limiting step in the Salvage Pathway
Enters the NAD+ pool where it is needed — inside the cell
What longevity researchers study as an NAD+ restoration strategy
The molecule cells actually use — and what aging depletes.
A dinucleotide — larger and more complex than NMN
Poor oral bioavailability — does not cross cell membranes easily in intact form
Must be produced intracellularly from precursors including NMN
Consumed by sirtuins, PARPs, and CD38 — constantly recycled or replenished
Declines 40–50% from young adulthood to middle age in research models
The actual substrate whose availability governs cellular maintenance capacity
The NAD+ Enzyme System
The enzymes that connect NMN
to the biology of aging.
Every major enzyme in this system has a direct relationship to NMN and NAD+ — either producing them, consuming them, or degrading them. Together they form the cellular machinery whose declining efficiency with age is what NMN research is fundamentally attempting to address.
The enzyme that makes NMN — and whose decline with age is one reason NMN research began
NAMPT — nicotinamide phosphoribosyltransferase — converts nicotinamide to NMN in the Salvage Pathway. It is the rate-limiting step: when NAMPT activity is high, the pathway flows efficiently; when it declines, the entire NAD+ recycling system slows. Research has documented that NAMPT expression and activity decline with age in multiple tissues. This decline is one of the primary mechanistic explanations for age-related NAD+ insufficiency — and one of the reasons that supplying NMN directly, bypassing the NAMPT bottleneck, has been a central strategy in the NAD+ restoration research literature.
The enzyme that converts NMN directly to NAD+ — the final step in the pathway
NMNAT — nicotinamide mononucleotide adenylyltransferase — performs the single enzymatic step that converts NMN to NAD+. It exists in three isoforms (NMNAT1, NMNAT2, NMNAT3) distributed across different cellular compartments: the nucleus, the cytoplasm, and mitochondria. The existence of these compartment-specific isoforms reflects the fact that NAD+ must be maintained separately in each cellular compartment — the mitochondrial NAD+ pool, for example, is functionally distinct from the nuclear pool and is replenished through its own NMNAT3-mediated conversion. NMN's ability to reach each compartment and be converted locally is one of the reasons researchers have examined it with particular interest.
The NAD+-consuming enzymes most directly associated with longevity biology
The seven mammalian sirtuins (SIRT1–7) are NAD+-dependent deacylases — they require NAD+ to perform their regulatory functions and consume it in the process. Their combined activities span chromatin regulation, DNA repair coordination, mitochondrial biogenesis, metabolic adaptation, and circadian rhythm maintenance. Foundational research establishing the link between NAD+, sirtuins, and aging — from Guarente's work on Sir2 in yeast to Sinclair's laboratory's identification of the NAD+-sirtuin axis in mammalian aging — is what elevated NAD+ biology from a biochemistry curiosity to one of the central subjects of longevity science.
The NAD+-consuming enzyme whose age-related increase compounds the decline in NAD+ production
CD38 is a multifunctional enzyme that degrades NAD+ and generates signaling molecules involved in calcium homeostasis and immune function. Research published in Cell Metabolism documented that CD38 expression increases substantially in aged tissues — and that CD38-knockout mice maintain higher NAD+ levels as they age, with corresponding metabolic benefits. The age-related rise in CD38 represents a second front in the NAD+ depletion story: while NAMPT decline reduces production, rising CD38 accelerates degradation. The compounding of these two dynamics across decades of aging is part of the mechanistic explanation for the depth of NAD+ decline documented in the research literature. Studies were conducted independently and did not involve any specific Codeage product.
The Research in Numbers
What the NMN–NAD+
relationship looks like in data.
1 step
Enzymatic conversions between NMN and NAD+
NMN requires a single enzymatic step — performed by NMNAT — to become NAD+. This directness distinguishes it from precursors further upstream in the pathway, such as tryptophan or nicotinic acid, which require multiple enzymatic conversions and are subject to greater flux variability. The one-step relationship is a significant reason for NMN's prominence in the NAD+ restoration research literature.
3
Distinct cellular compartments with separate NAD+ pools maintained by NMNAT isoforms
The nucleus, cytoplasm, and mitochondria each maintain distinct NAD+ pools, replenished by the three NMNAT isoforms specific to each compartment. This compartmentalization means that NAD+ availability must be managed separately across the cell — and that a precursor capable of reaching each compartment matters for the comprehensiveness of NAD+ restoration.
500+
Enzymatic reactions estimated to require NAD+ or NADH as a cofactor
Estimates of NAD+-dependent enzymatic reactions in human biology exceed 500 — a breadth of biological dependency that explains why NAD+ decline has such wide-ranging downstream effects and why restoring its availability has attracted sustained research interest across cardiovascular, metabolic, neurological, and musculoskeletal biology. It is not one pathway that NAD+ supports. It is the underlying chemistry of cellular function itself.
III
What the relationship means
for how longevity science thinks about aging.
The NMN–NAD+ relationship is not simply a biochemical curiosity. It is, in the view of the researchers who have spent decades studying it, a window into a fundamental architecture of how cells age — and one of the clearest mechanistic connections between a declining biological process and the broad landscape of age-related cellular deterioration.
The logic runs as follows: NAD+ is required by the enzyme systems that maintain cellular integrity. Those enzyme systems — sirtuins, PARPs, the mitochondrial complexes — decline in function as NAD+ declines. And that decline in maintenance function is associated with the accumulation of molecular damage, epigenetic dysregulation, metabolic dysfunction, and tissue deterioration that characterizes biological aging. NAD+ decline is not the only driver of aging. But it is a driver that connects, through a single molecular axis, to a remarkably broad range of age-related changes — and that has a known precursor, in NMN, which the body is capable of converting to NAD+ efficiently.
This is the intellectual foundation of the NMN research program. Not a claim that NMN reverses aging. Not a promise of a specific outcome. A serious scientific hypothesis — well-supported in animal models, actively being tested in humans — that restoring NAD+ availability through its most direct precursor may matter for how cells function as they age. Understanding that hypothesis, its mechanistic basis, and the state of the evidence for it is what allows the Codeage approach to Cellular Longevity to be built on science rather than marketing. To go deeper on the foundational NMN science, the NMN foundations article covers the research history in full.
NAD+ decline connects,
through a single molecular axis,
to a remarkably broad range
of age-related cellular changes.
Codeage · Pillar 03 · Cellular Longevity
Built for the
cellular long game.
Cellular Longevity is Pillar 03 of The Longevity Code — the dimension of the system built around NAD+ biology, mitochondrial health, and the science of cellular aging.
Explore Cellular Longevity →
